X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Transgene Biotek Ltd.
BSE CODE: 526139   |   NSE CODE: NA   |   ISIN CODE : INE773D01018   |   13-Feb-2026 Hrs IST
BSE NSE
Rs. 2.59
0.1 ( 4.02% )
 
Prev Close ( Rs.)
2.49
Open ( Rs.)
2.80
 
High ( Rs.)
2.80
Low ( Rs.)
2.35
 
Volume
128763
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Source DateBoard Meeting DateDetails
28-Jan-2026 13-Feb-2026 Quarterly Results
31-Oct-2025 14-Nov-2025 Quarterly Results
30-Jul-2025 07-Aug-2025 Quarterly Results
28-Apr-2025 07-May-2025 Audited Results
17-Jan-2025 24-Jan-2025 Quarterly Results
04-Nov-2024 12-Nov-2024 Quarterly Results & A.G.M.
19-Jul-2024 10-Aug-2024 Quarterly Results
13-May-2024 30-May-2024 Quarterly Results & Audited Results
29-Jan-2024 14-Feb-2024 Quarterly Results
06-Nov-2023 14-Nov-2023 Quarterly Results & Inter alia, to consider and approve:- 2. To consider and approve the appointment of M/s.Vasavi & Co, chartered Accountants as Statutory Auditors of the Company for a period of Five years from the financial year 2023-24 upto-2027-2028, subject to the approval of members in the ensuing annual general meeting. 3. To consider and approve the appointment of M/s.Manisha Dubey, as internal auditor of the Company for financial year 2023-24. 4. To consider and approve the Notice of the 33 rd Annual General meeting for the Financial Year 2022-2023 and other related matters thereto. 5. To consider and approve Directors? Report and the annexure thereon for the Financial Year 2022-2023. 6. To transact such other business as may be required.
Page 1 of 11
PREV || NEXT